Eva-Maria Collnot

16 papers receiving 1.9k citations

Peers

Eva-Maria Collnot
Comparison fields: 5 of 125
  • Pharmaceutical Science 665
  • Biomaterials 478
  • Molecular Medicine 90
  • Chemical Health and Safety 8
  • Oncology 325
Replace Kang Choon Lee with:
Kang Choon Lee South Korea
Lingli Chen China
Annalaura Stammati Italy
Farshad H. Shirazi Iran
Ebrahim Azizi Iran
Ahmed Alalaiwe Saudi Arabia
Srikanta Kumar Rath India
Peidi Hu United States
Albin Kristl Slovenia
Eva-Maria Collnot relative to Kang Choon Lee South Korea Kang Choon Lee's profile →
Citations per field
00.5×6.8×
Kang Choon Lee · 1×
Citations per year

Countries citing papers authored by Eva-Maria Collnot

Since Specialization
Citations

This map shows the geographic impact of Eva-Maria Collnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva-Maria Collnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva-Maria Collnot more than expected).

Fields of papers citing papers by Eva-Maria Collnot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva-Maria Collnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva-Maria Collnot. The network helps show where Eva-Maria Collnot may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva-Maria Collnot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva-Maria Collnot Line = papers co-authored together Eva-Maria Collnot links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2007244
2 2012212
3 2011212
4 2010190
5 2012189
6 2010175
7 2006154
8 2013109
9 2005100
10 201484
11 201582
12 201569
13 201546
14 202021
15 20138
16 20158

About Eva-Maria Collnot

Eva-Maria Collnot is a scholar working on Pharmaceutical Science, Developmental Neuroscience, Genetics, Gastroenterology and Electrochemistry, having authored 16 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers), Advanced Drug Delivery Systems (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Nanoparticle-Based Drug Delivery (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Nanoparticles: synthesis and applications (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). The work is most often cited by research in Pharmaceutical Science (665 citations), Biomaterials (478 citations), Molecular Medicine (90 citations), Chemical Health and Safety (8 citations) and Oncology (325 citations). Eva-Maria Collnot has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Claus‐Michael Lehr, Christiane Baldes, Hussain Ali, Kevin J. Edgar, Michael F. Wempe, Ulrich F. Schaefer, Fransisca Leonard, John A. Hyatt, Karl Kolter and Michael Linn. Their work appears in journals such as Molecular Pharmaceutics, Journal of Controlled Release, Pharmaceutical Research, Nanotoxicology and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026